SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Attention is centered on reports that Papa Johns largest U.S. franchisee has joined Irth Capitals effort to take the company private, reviving buyout hopes. Traders see the franchisees involvement as strengthening the proposal, while others remain skeptical that the board will approve a deal or that negotiations will produce a signed transaction.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Phase 3 results for Amgens IMDELLTRA-plus-IMFINZI combination in extensive-stage small-cell lung cancerreported to reduce the risk of death by 58%are driving discussion, with traders viewing the data as a potential growth opportunity. Some also point to Repathas sales growth as a key business driver and debate whether the lung-cancer program can become a major contributor.

TOSHI

TOSHI is drawing attention around a hoped-for breakout after bursts of volume and a modest rebound, with traders repeatedly watching a stubborn resistance zone and speculating about a short squeeze. Bulls are accumulating and anticipating a run, while skeptics point to repeated rejections, weak price action, and broader crypto-market risk; rumors of listings or an announcement remain unconfirmed.

Palo Alto Networks, is a cybersecurity company that provides cybersecurity platforms and services to enterprises, organizations, service providers, and government entities. Its offerings include network and AI security, cloud security, security operations, and identity security solutions. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks rallied with cybersecurity peers as traders focused on an Evercore ISI survey indicating enterprise security budgets are firming and on escalating vulnerability and AI-driven cyberthreat concerns. The move drew bullish momentum commentary, while some traders questioned whether the sectors gains are justified given lofty valuations.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Updated ESMO subgroup analyses from Celcuitys Phase 3 VIKTORIA-1 breast-cancer study are driving discussion, with traders highlighting favorable efficacy for gedatolisib and the potential for a PIK3CA-mutant label expansion. The reaction is split between enthusiasm for the data and concern that CELC still needs to demonstrate commercial uptake and revenue; some posts also debate whether the share price reflects the clinical results.

iShares Trust - iShares Biotechnology ETF

iShares Biotechnology ETF

A broad biotech-sector pullback is the main focus, with IBB hovering near its 50-day moving average after a strong run. Traders describe the dip as a pause while others remain cautious about sector weakness, and several note that large-cap biotech is holding up better than smaller names.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. The firm offers various products for application security, performance and reliability, network services, Zero Trust, developer platform, media delivery, insights, domain registration, and consumer services. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare shares are drawing attention after a sharp gain tied to the PHP2Shell web-software vulnerabilities: traders see its web application firewall as a potential beneficiary as site operators seek protection, alongside a broader cybersecurity-stock rally. Some participants are bullish on the security-demand angle, while others focus on the stocks high valuation and trade the move cautiously.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Attention centers on Merck and Modernas Phase 3 melanoma-vaccine results: the personalized vaccine combined with Keytruda met trial endpoints, but traders debate whether the benefit and future commercial potential justify expectations, with some viewing the share pullback as a sell the news reaction. The treatment is not yet approved, and its broader use remains uncertain.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

Promising lung-cancer trial updates for BioNTechs oncology pipeline, including pumitamig and gotistobart, are drawing attention, with traders highlighting encouraging response and survival data. The reaction is bullish but tempered by questions about how durable the results are and lingering concerns over earlier clinical setbacks and leadership changes.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

GEOs sale of its Adelanto facilities to DHS and the resulting debt-reduction and buyback flexibility are driving discussion. Traders see the transaction as a balance-sheet positive, while others question the stocks weakness and weigh the benefits against giving up ownership economics; many are looking for clarity on further sales.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CVR Partners to Release Third Quarter 2026 Earnings Results

CVR Partners, LP (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate (UAN) solution fertilizer products, plans to release its third quarter 2026 earnings results on Tuesday, November 3, before the opening of trading on the New York Stock Exchange. The Partnership also will host a...

Trump's Russia Tariff Waiver Helps Apple, Eliminates Tariff Advantage for CF and CVR Partners

Trump's waiver of steep Russiarelated tariffs gives Apple temporary relief while denying fertilizer makers like CF Industries and CVR Partners a potential shield. The move reshapes outlooks across tech, energy, refining, and agriculture as Washington's sanctions strategy shifts again.read more...

CVR Partners Reports Second Quarter 2026 Results

CVR Partners, LP (CVR Partners or the Partnership) (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate (UAN) solution fertilizer products, today announced net income of $78 million, or $7.33 per common unit, and EBITDA of $107 million on net sales of $202 million for the second quarter...

CVR Partners to Release Second Quarter 2026 Earnings Results

CVR Partners, LP (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate (UAN) solution fertilizer products, plans to release its second quarter 2026 earnings results on Wednesday, July 29, after the close of trading on the New York Stock Exchange. The Partnership also will host a...

CVR Partners 2025 Schedule K-3 Now Available

CVR Partners, LP (NYSE: UAN) today announced that 2025 Schedule K-3s, reflecting items of international tax relevance, are now available online. Unitholders may access the information at www.taxpackagesupport.com/cvrpartners.A limited number of investors (primarily foreign unitholders, unitholders...

CVR Energy and CVR Partners Announce Leadership Changes

CVR Energy, Inc. (NYSE: CVI or CVR Energy) and CVR Partners, LP (NYSE: UAN or CVR Partners) are pleased to announce that Dane Neumann, Executive Vice President and Chief Financial Officer, has been promoted to the position of President and Chief Executive Officer of CVI and the general partner of...

CVR Partners Q1 Earnings Call Highlights

CVR Partners (NYSE:UAN) reported first-quarter 2026 results highlighted by higher nitrogen fertilizer pricing and strong plant performance, while management pointed to tightening global supply conditions amid geopolitical disruptions as a key driver of market strength.

First-quarter financial and o...

CVR Partners (NYSE:UAN) Raised to Buy at Wall Street Zen

Wall Street Zen raised CVR Partners from a 'hold' rating to a 'buy' rating in a research report on Saturday...

Transcript: CVR Partners Q1 2026 Earnings Conference Call

CVR Partners, LP (NYSE:UAN) Announces Dividend Increase - $4.00 Per Share

CVR Partners, LP (NYSE:UAN) announced a quarterly dividend on Wednesday, April 29th. Shareholders of record on Monday, May 11th will be paid a dividend of 4.00 per share by the basic materials...

CVR Partners LP is a holding company, which engages in the nitrogen fertilizer business. Its products include ammonia and urea ammonium nitrate fertilizers. The company was founded on June 1, 2007 and is headquartered in Sugar Land, TX.

CVR Partners LP - Unit

CF, UAN Stocks Rally On Supply Shock Due To Middle East Disruptions – Here’s Why Analysts See Further Upside

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>UBS raised its price target on CF Industries to $140 from $97, according to The Fly.</li><li>The firm said there is potential for further upside in nitrogen prices and CF’s earnings.</li><li>UAN stock has outperformed peers Intrepid, Mosaic and Nutrien.</li></ul>CF Industries (CF) and CVR Partners (UAN) stocks have emerged as standout leaders in the fertilizer space, each rallying more than 30% since U.S.-Israel strikes on Iran escalated tensions late last month, triggering a sharp spike in global nitrogen prices and tightening supply chains.At the time of writing, both <a href="https://stocktwits.com/symbol/CF">CF</a> and <a href="https://stocktwits.com/symbol/UAN">UAN shares</a> gained about 0.5% on Friday.<h2 class="st-heading-2">Why The Middle East Matters For Urea?</h2>Recently, RBC Capital Markets noted that the Middle East accounts for about 35% - 40% of global urea exports, a larger share than its share of crude oil exports. Rising LNG prices are also pushing up nitrogen fertilizer production costs, which could benefit companies like CF Industries.Meanwhile, Urea FOB US Gulf futures for April 2026 deliveries have surged more than 50% since the war in the Middle East began.<h2 class="st-heading-2">Fertilizer Stocks: Analysts See More Room For Rally</h2>On Thursday, UBS raised its price target on CF Industries to $140 from $97 while maintaining a ‘Neutral’ rating, according to The Fly. The firm said there is potential for further upside in nitrogen prices and CF’s earnings, as current market prices may not fully reflect the severity of ongoing industry disruptions.Last week, BMO Capital Markets raised its price target on CF Industries to $140 from $115 and maintained an Outperform rating, citing expectations that elevated prices for nitrogen, phosphate, sulfur, and methanol will persist in the near term.Both UAN and CF have significantly outperformed key fertilizer stocks, including <a href="https://stocktwits.com/symbol/IPI">Intrepid Potash</a> (+22%), <a href="https://stocktwits.com/symbol/NTR">Nutrien</a> (-2%), and <a href="https://stocktwits.com/symbol/MOS">Mosaic</a> (-9%) since the war began.<h2 class="st-heading-2">Retail Investors Remain Cautious&nbsp;</h2>Retail sentiment for both CF and UAN stocks was ‘bearish’ on Stocktwits. However, chatter was mixed.One investor believes that CF could crash to $100 once Iran re-opens the Strait of Hormuz.<stembedurl>https://stocktwits.com/BlackFlag1984/message/648656100</stembedurl>One user tracking UAN said the stock can go “way higher given the fertilizer crisis that is about to unfold.”<stembedurl>https://stocktwits.com/Noam_Stonksky/message/647009085</stembedurl>CF Industries, the world’s largest producer of ammonia, converts it into products such as urea, urea ammonium nitrate, and ammonium nitrate. CVR Partners produces ammonia, urea, and ammonium nitrate fertilizers.Year-to-date, CF shares have surged 71% while UAN has gained 34%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A candlestick chart can be seen in a trading platform on a smartphone. Top U.S. firms announced record buybacks this year. (Photo by Silas Stein/picture alliance via Getty Images)

Ammonia-based urea producers CF Industries and CVR Partners have gained more than 30% each since the conflict began, leading to a surge in global urea prices.  

This Overlooked Commodity Is Spiking 50% –And These Stocks Are Cashing In

CF Industries Holdings Inc

Mosaic Company

CVR Partners, LP Common Units r

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$125.44
Prev Close	$125.23
Open	$126.80
Dividend Yield	11.63%
50-Day Moving Average	$127.60
Beta	0.24
Avg. Volume	26,907.21
PE Ratio	8.28

52-Week High	$139.50
52-Week Low	$91.44
Market Capitalization	$1.33B
EPS (Annual)	$9.33
Price to Book	3.82
Revenue Per Employee	$1.89M

Feed

News

Sentiment

Earnings

Fundamentals

Info

UAN Fundamentals